Journal
NANOMEDICINE
Volume 10, Issue 21, Pages 3275-3286Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/nnm.15.169
Keywords
EU; global challenges; governance; health and safety; innovation; intellectual property; nanomaterials; regulation; USA
Ask authors/readers for more resources
Nanomedicine will play an increasing role in prevention and treatment across the entire healthcare spectrum. However, their precise market size, economic value and areas of application remain unclear. This opacity, including the question of what constitutes nanomedicine matters, especially when considered alongside the key regulatory questions and concerns. This article begins by placing these key questions into context in relation to the current scientific state of the art, focusing particular attention on the human health and safety context. In exploring these central questions surrounding the regulation of nanomedicine, this perspective also explores existing and suggested frameworks that aim to deal with emerging technologies more generally. It then outlines priority areas for action and general conclusions specific to nanomedicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available